Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial.
Takeshi MorimotoIchiro SakumaMio SakumaAkihiro TokushigeMasahiro NatsuakiTomohiro AsahiMichio ShimabukuroTakashi NomiyamaOsamu ArasakiKoichi NodeShinichiro UedaPublished in: Scientific reports (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.